Comprehensive Evaluations of Health Care Interventions: The Realism-Transparency Tradeoff

Abstract

Get full access to this article

View all access options for this article.

References

Engel G . The need for a new medical model: a challenge for biomedicine. Science. 1977;196:129–136.

Chiou CF , Hay JW , Wallace JF , et al. Development and validation of a grading system for the quality of cost-effectiveness studies. Med Care. 2003:41:32–44.

Weinstein MC , O’Brien B , Hornberger J , et al. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices–Modeling Studies. Value Health. 2003;6:9–17.

Drummond MF , Barbieri M , Wong JB . Analytic choices in economic models of treatments for rheumatoid arthritis: what makes a difference? Med Decis Making. 2005;25:520–533.

Irwig L , Tosteson AN , Gatsonis C , et al. Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med. 1994;120:667–676.

Hawkins N , Sculpher M , Epstein D . Cost-effectiveness analyses of treatments for chronic disease: using R to incorporate time-dependency of treatment response. Med Decis Making. 2005; 25:511–519.

Eddy DM , Schlessinger L . Archimedes: a trial-validated model of diabetes. Diabetes Care. 2003;26:3093–3101.

Garber AM , MaCurdy TE . Nursing home discharges and exhaustion of Medicare benefits. J Am Stat Assoc. 1993;88:727–736.

Hawkins N , Epstein D , Drummond MF , et al. Assessing the cost-effectiveness of new pharmaceuticals in epilepsy in adults: the results of a probabilistic decision model. Med Decis Making. 2005;25:493–510.

10.

Man-Son-Hing M , Gage BF , Montgomery AA , et al. Preference-based antithrombotic therapy in atrial fibrillation: implications for clinical decision making. Med Decis Making. 2005;25:548–559.